Esta buscando: Pyrimethamine

17 results were found

Refinar resultados Ordenado por

Sort Results

Vista lista Vista Extendida (Nueva)

Comparar(0) Clear

Valore los resultados de su búsqueda

Pyrimethamine, analytical standard, VETRANAL™, Supelco®

Numero del catalogo: (46706-250MG)

Proveedor: Merck

Descripción: Organic Standard, Pyrimethamine

UOM: 1 * 250 mg

Certificados Promoción

N/A Each

Pyrimethamine 98%

Proveedor: Thermo Scientific

Descripción: Pyrimethamine 98%

Pyrimethamine ≥98.0% (by HPLC, titration analysis)

Proveedor: TCI

Descripción: Pyrimethamine ≥98.0% (by HPLC, titration analysis)

Pyrimethamine, Reference Standard

Numero del catalogo: (1589007.)

Proveedor: USP

Descripción: USP Reference Standards are specified for use in conducting official USP–NF tests and assays. USP also provides Reference Standards specified in the Food Chemicals Codex as well as authentic substances—high-quality chemical samples—as a service to analytical, clinical, pharmaceutical and research laboratories. To confirm accuracy and reproducibility, USP Reference Standards are rigorously tested and evaluated by multiple independent laboratories including USP, commercial, regulatory, and academic labs. USP also provide publicly available, official documentary standards for pharmaceutical ingredients in the USP–NF that link directly with our primary reference standards.

UOM: 1 * 200 mg

Promoción

N/A Each

Metotrexato, yellow powder Ph. Eur., USP

Proveedor: MP Biomedicals

Descripción: Methotrexate is a cell cycle arresting agent with varying effects. Methotrexate has been reported to arrest the cell cycle in late G1/S thus leading to the inhibition of the synthesis of DNA, RNA, thymidylates, and proteins. The main mechanism of action is reported to involve the inhibition of enzymes involved in purine metabolism which leads to the accumulation of adenosine or the suppression of intercellular adhesion molecule expression by T cells. Additionally, this compound has been observed to inhibit DHFR.
Methotrexate is used for chemotherapy either alone or in combination with other agents. It is effective for the treatment of a number of cancers including: breast, head and neck, leukemia, lymphoma, lung, osteosarcoma, bladder, and trophoblastic neoplasms. It is also used in treatment of autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions. It is used to inhibit dihydrofolate reductase in DHFR-based protein expression systems. Also effective in treatment of pyrimethamine-resistant Plasmodium vivax malaria parasites.
Potent inhibitor of dihydrofolate reductase and agent for antitumor studies. Use to inhibit dihydrofolate reductase in DHFR-based protein expression systems. Also shows immunosuppressive effects in, e.g., rheumatoid arthritis.
Methotrexate is an allosteric inhibititor of dihydrofolate reductase (DHFR), the enzyme that catalyzes the conversion of dihydrofolate to tetrahydrofolate. Since tetrahydrolfolate is required for purine and pyrimidine synthesis, methotrexate treatment results in the inhibition of DNA and RNA synthesis.